Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing 26 pseudogene (LOC643348, ENSG00000231317), also referred to as the "coiled-coil domain containing 144C pseudogene," is a *pseudogene* located on chromosome 7p11.2 that is related by sequence to the functional ANKRD26 gene. As a pseudogene, LOC643348 does not encode a functional protein and is not known to possess biological functions, disease relevance, or therapeutic target potential. There is no evidence supporting involvement in biological pathways, interaction with drugs, or use as a biomarker. This entry should not be considered a therapeutic target, and its alternate names reflect annotation convention, not functional significance[4][6][8][12]. **Reasoning & details:** - This is a **pseudogene**: it is annotated as non-protein-coding and is not regarded as a functional gene in any disease, therapeutic context, or drug interaction database[4][6][8]. - It is unrelated to the functional **coiled-coil domain family proteins** or to the functional ANKRD26 protein, which does have roles in platelets and some diseases—this entry is for the pseudogene, *not* the protein-coding gene[4][12][17]. - There is no evidence for its use or consideration as a therapeutic target, biomarker, or involvement in drug response. If more precise functional data emerge, the information above may require revision, but as of current knowledge, this is not a valid therapeutic or research target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing 26 pseudogene.